Article

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage

2021-09-16

Abstract excerpt

<h4>ABSTRACT</h4> The E484K mutation at the SARS-CoV-2 Spike protein emerged independently in different variants around the world, probably as part of the ongoing adaptation of the virus to the human host, and has been widely associated with immune escape from neutralizing antibodies generated during previous infection or vaccination. In this work, the B.1+L249S+E484K lineage was isolated along with A.1, B.1.420 a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0e1a65b7-5d77-5554-ab58-0a0e16eddbda
DOI: 10.1101/2021.09.13.21263430

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineageDOI 10.1101/2021.09.13.21263430Read

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage.Semantic proximity Read

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?Semantic proximity Read

Emerging SARS-CoV-2 Variant B.1.1.7 Reduces Neutralization Activity of Antibodies Against Wild-Type SARS-CoV-2Semantic proximity Read

Human primary Omicron BA.1 and BA.2 infections result in sub-lineage-specific neutralizationSemantic proximity Read

SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodiesSemantic proximity Read

Antibody neutralization to SARS-CoV-2 and variants after one year in WuhanSemantic proximity Read

SARS CoV-2 escape variants exhibit differential infectivity and neutralization sensitivity to convalescent or post-vaccination seraSemantic proximity Read

SARS-CoV-2 spike E484K mutation reduces antibody neutralisationSemantic proximity Read

SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Semantic proximity Read

Ultrapotent SARS-CoV-2 neutralizing antibodies effectively block new-emerging mutational variantsSemantic proximity Read

Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients.Semantic proximity Read

Hybrid immunity improves B cell frequency, antibody potency and breadth against SARS-CoV-2 and variants of concernSemantic proximity Read